Continuing Medical Education
Cleveland Clinic Center for Continuing Education
The Center for Continuing Education is committed to sharing a wealth of knowledge with physicians, nurses, and other medical professionals worldwide for more than 80 years. Its objective is to provide high-quality, innovative educational programs that increase the knowledge of health care providers, resulting in improved patient outcomes.
American Society of Clinical Oncology (ASCO)
Featured Abstracts from the 2023 Annual Meeting
- 10 ASCO Presentations You Don’t Want to Miss
- First-in-Class Bifunctional EGFR/ TGF-β Inhibitor Shows Promising Activity in Metastatic Head and Neck Cancers, Especially When Given with Immunotherapy
- Foundational Research Yields Clues to Understanding Early-Onset Colorectal Cancer
- Luspatercept Shows Promise as Treatment for Anemia in Patients With Myelofibrosis
- Population-Based Analysis Highlights Disparities in Lung Cancer Mortality in U.S.
- Enfortumab Plus Pembrolizumab May Represent New First-Line Standard in Advanced Urothelial Cancer
- Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials
American Society for Radiation Oncology (ASTRO)
Featured Abstracts from the 2023 Annual Meeting
- Top 10 Presentations You Don’t Want to Miss at ASTRO 2023.
- Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma is Cost-Effective in Southern China.
- Phase 1 Study Supports Dose-Escalating Preoperative SRS for Large Brain Metastases.
- Quality Metrics and Quality Improvement Program Can Improve Cervical Cancer Care.
- Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment.
- Studying Ultra-Hypofractionated Radiotherapy for Soft Tissue Sarcoma.
American Society of Hematology (ASH)
Featured Abstracts from the 2022 Annual Meeting
- Tranexamic Acid Offers Better Control of Heavy Menstrual Bleeding in Patients with Von Willebrand Disease.
- Study Finds Biomarkers of Complications in Patients with Cancer Diagnosed with COVID-19.
- Researchers Identify Risk Factors of Secondary Malignancy in Breast Cancer Survivors.
- Study Provides Insights about Chemorefractory Diffuse Large B-Cell Lymphoma.
- Sustained Response Observed in MOMENTUM Trial of Patients with Myelofibrosis.
